A carregar...
Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events
In recent years, immune checkpoint inhibitors have emerged as effective therapies for advanced neoplasias. As new checkpoint target blockers become available and additional tumor locations tested, their use is expected to increase within a short time. Immune-related adverse events (irAEs) affecting...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4943391/ https://ncbi.nlm.nih.gov/pubmed/27306911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0509 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|